< Annex XII: Declaration regarding methyl bromide Up one level Decision VIII/1: Ratification of the Vienna Convention, the Montreal Protocol and its Amendments > Eighth Meeting of the Parties Decision VIII/1: Ratification of the Vienna Convention, the Montreal Protocol and its Amendments Decision VIII/2: Data and information provided by the Parties in accordance with Articles 7 and 9 of the Montreal Protocol Decision VIII/3: Membership of the Implementation Committee Decision VIII/4: Replenishment of the Multilateral Fund and three-year rolling business plan for 1997-99 Decision VIII/5: Actions to improve the functioning of the Financial Mechanism Decision VIII/6: Contributions to the Multilateral Fund Decision VIII/7: Measures taken to improve the Financial Mechanism and technology transfer Decision VIII/8: Membership of the Executive Committee of the Multilateral Fund Decision VIII/9: Essential-use nominations for Parties for controlled substances for 1997 through 2002 Decision VIII/10: Actions by Parties to promote industry's participation on a smooth and efficient transition away from CFC-based MDIs Decision VIII/11: Measures to facilitate a transition by a Party from CFC-based MDIs Decision VIII/12: Information gathering on a transition to non-CFC treatments for asthma and chronic obstructive pulmonary disease for Parties not operating under Article 5 Decision VIII/13: Uses and possible applications of hydrochlorofluorocarbons (HCFCs) Decision VIII/14: Further clarification of the definition of "Bulk substances" under decision I/12A Decision VIII/15: Control of trade in methyl bromide with non-Parties Decision VIII/16: Critical agricultural uses of methyl bromide Decision VIII/17: Availability of halons for critical uses Decision VIII/18: List of products containing controlled substances in Group II of Annex C (Hydrobromofluorocarbons) of the Protocol Decision VIII/19: Organization and functioning of the Technology and Economic Assessment Panel Decision VIII/20: Illegal imports and exports of controlled substances Decision VIII/21: Revised formats for reporting data under Article 7 of the Protocol Decision VIII/22: Compliance with the Montreal Protocol by Latvia Decision VIII/23: Compliance with the Montreal Protocol by Lithuania Decision VIII/24: Non-compliance by the Czech Republic with the halon phase-out by 1994 Decision VIII/25: Compliance with the Montreal Protocol by the Russian Federation Decision VIII/26: Exports of ozone-depleting substances and products containing ozone-depleting substances Decision VIII/27: Co-Chairs of the Open-ended Working Group of the Parties to the Montreal Protocol Decision VIII/28: Financial Matters: financial report and budgets Decision VIII/29: Application of Georgia for developing country status under the Montreal Protocol Decision VIII/30: Ninth Meeting of the Parties to the Montreal Protocol Annex I: Multilateral Fund: scale of 1997-1999 contributions Annex II: Recommended nominations for essential use exemptions Annex III: Recommended adjustments to quantities approved earlier for essential uses Annex IV: Reporting accounting framework for essential uses other than laboratory and analytical applications Annex V: Terms of reference of the Technology and Economic Assessment Panel (TEAP) Annex VI: Trust Fund for the Montreal Protocol: scale of 1997-1998 contributions Annex VII: Trust Fund for the Montreal Protocol: budgets for 1996, 1997 and 1998 Annex VIII: Note on the status of the Multilateral Fund < Annex XII: Declaration regarding methyl bromide Up one level Decision VIII/1: Ratification of the Vienna Convention, the Montreal Protocol and its Amendments >
